6.
Sowers M, Eyvazzadeh A, McConnell D, Yosef M, Jannausch M, Zhang D
. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008; 93(9):3478-83.
PMC: 2567855.
DOI: 10.1210/jc.2008-0567.
View
7.
Taylor A, Adams J, Mulder J, Martin K, Sluss P, Crowley Jr W
. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab. 1996; 81(10):3615-21.
DOI: 10.1210/jcem.81.10.8855811.
View
8.
Goswami D, Conway G
. Premature ovarian failure. Hum Reprod Update. 2005; 11(4):391-410.
DOI: 10.1093/humupd/dmi012.
View
9.
Russell N, Gilmore A, Roudebush W
. Clinical Utilities of Anti-Müllerian Hormone. J Clin Med. 2022; 11(23).
PMC: 9741321.
DOI: 10.3390/jcm11237209.
View
10.
Anagnostou E, Mavrogianni D, Prifti I, Dimitroulia E, Protopapas A, Drakakis P
. The Role of FSHR SNPs and AMH in Follicular Fluid and Serum in Ovarian Response during COS: A Pilot Study. Int J Reprod Med. 2021; 2021:8685158.
PMC: 7889364.
DOI: 10.1155/2021/8685158.
View
11.
Fortuno C, Labarta E
. Genetics of primary ovarian insufficiency: a review. J Assist Reprod Genet. 2014; 31(12):1573-85.
PMC: 4250468.
DOI: 10.1007/s10815-014-0342-9.
View
12.
Richards J, Pangas S
. The ovary: basic biology and clinical implications. J Clin Invest. 2010; 120(4):963-72.
PMC: 2846061.
DOI: 10.1172/JCI41350.
View
13.
Jankowska K
. Premature ovarian failure. Prz Menopauzalny. 2017; 16(2):51-56.
PMC: 5509972.
DOI: 10.5114/pm.2017.68592.
View
14.
Knauff E, Eijkemans M, Lambalk C, Ten Kate-Booij M, Hoek A, Beerendonk C
. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2008; 94(3):786-92.
DOI: 10.1210/jc.2008-1818.
View
15.
Karagiorga I, Partsinevelos G, Mavrogianni D, Anagnostou E, Zervomanolakis I, Kallianidis K
. Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology. J Assist Reprod Genet. 2014; 32(3):357-67.
PMC: 4363245.
DOI: 10.1007/s10815-014-0403-0.
View
16.
Alipour F, Rasekhjahromi A, Maalhagh M, Sobhanian S, Hosseinpoor M
. Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure. Dis Markers. 2015; 2015:585604.
PMC: 4465760.
DOI: 10.1155/2015/585604.
View
17.
Kruszynska A, Slowinska-Srzednicka J
. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Prz Menopauzalny. 2017; 16(2):47-50.
PMC: 5509971.
DOI: 10.5114/pm.2017.68591.
View
18.
Papanikolaou I, Giannelou P, Anagnostou E, Mavrogianni D, Drakakis P, Loutradis D
. Combined study on the single nucleotide polymorphisms in the follicle-stimulating hormone receptor (Ser680Asn) and anti-Müllerian hormone receptor type II (-482A>G) as genetic markers in assisted reproduction. Horm Mol Biol Clin Investig. 2019; 38(1).
DOI: 10.1515/hmbci-2018-0077.
View
19.
Wu C, Yang S, Tsao H, Chang Y, Lee T, Lee M
. Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles. Int J Environ Res Public Health. 2019; 16(5).
PMC: 6427679.
DOI: 10.3390/ijerph16050841.
View
20.
Zouboulis C, Achenbach A, Makrantonaki E
. Acne tarda and male-pattern baldness unmasking primary ovarian insufficiency: a case and review. Dermatology. 2014; 229(2):51-4.
DOI: 10.1159/000362595.
View